World Journal of Gastroenterology 2017-Dec
Silymarin: An option to treat non-alcoholic fatty liver disease.
只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
关键词
抽象
We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation.